These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23242167)

  • 1. Inflammatory activation following interruption of long-term cardiac resynchronization therapy.
    Rubaj A; Ruciński P; Oleszczak K; Trojnar MK; Wójcik M; Wysokiński A; Kutarski A
    Heart Vessels; 2013 Sep; 28(5):583-8. PubMed ID: 23242167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High sensitivity C-reactive protein predicts nonresponders and cardiac deaths in severe heart failure patients after CRT implantation.
    Kamioka M; Suzuki H; Yamada S; Kamiyama Y; Saitoh S; Takeishi Y
    Int Heart J; 2012; 53(5):306-12. PubMed ID: 23038092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the effects of cardiac resynchronization therapy on pathophysiological pathways of heart failure using surrogate biomarkers.
    Sunman H; Özkan A; Yorgun H; Canpolat U; Karabulut E; Bayrak T; Kaya EB; Tokgözoğlu L; Özer N; Özkara A; Aytemir K; Oto A
    Cardiol J; 2018; 25(1):42-51. PubMed ID: 28980281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of cardiac resynchronization therapy on inflammatory biomarkers and cardiac remodeling: The paradox of functional and echocardiographic response.
    Almeida-Morais L; Abreu A; Oliveira M; Silva Cunha P; Rodrigues I; Portugal G; Rio P; Soares R; Mota Carmo M; Cruz Ferreira R
    Rev Port Cardiol (Engl Ed); 2018 Feb; 37(2):105-113. PubMed ID: 29503051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neopterin as a novel marker; well correlated with mortality and morbidity in patients with advanced systolic heart failure.
    Demir Ş; Ede H; Kaplan M; Yavuz F; Yücel C; Kurt İH
    Acta Cardiol; 2019 Jun; 74(3):216-221. PubMed ID: 29914304
    [No Abstract]   [Full Text] [Related]  

  • 6. Association between brain natriuretic peptide, markers of inflammation and the objective and subjective response to cardiac resynchronization therapy.
    Brouwers C; Versteeg H; Meine M; Heijnen CJ; Kavelaars AM; Pedersen SS; Mommersteeg PM
    Brain Behav Immun; 2014 Aug; 40():211-8. PubMed ID: 24704567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthermia by bathing in a hot spring improves cardiovascular functions and reduces the production of inflammatory cytokines in patients with chronic heart failure.
    Oyama J; Kudo Y; Maeda T; Node K; Makino N
    Heart Vessels; 2013 Mar; 28(2):173-8. PubMed ID: 22231540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cardiac resynchronization therapy on cardiac sympathetic nervous dysfunction and serum C-reactive protein level.
    Shinohara T; Takahashi N; Saito S; Okada N; Wakisaka O; Yufu K; Hara M; Nakagawa M; Saikawa T; Yoshimatsu H
    Pacing Clin Electrophysiol; 2011 Oct; 34(10):1225-30. PubMed ID: 21671958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain natriuretic peptide and the risk of ventricular tachyarrhythmias in mildly symptomatic heart failure patients enrolled in MADIT-CRT.
    Medina A; Moss AJ; McNitt S; Zareba W; Wang PJ; Goldenberg I
    Heart Rhythm; 2016 Apr; 13(4):852-9. PubMed ID: 26724489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Usefulness of N-terminal Prohormone of Brain Natriuretic Peptide and High Sensitivity Troponin T in Patients with Heart Failure Undergoing Cardiac Resynchronization Therapy.
    Debska-Kozlowska A; Ksiazczyk M; Warchol I; Lubinski A
    Curr Pharm Des; 2019; 25(14):1671-1678. PubMed ID: 31223080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of preimplantation B-type natriuretic peptide level for predicting response to cardiac resynchronization therapy.
    Lellouche N; De Diego C; Cesario DA; Vaseghi M; Horowitz BN; Mahajan A; Wiener I; Boyle NG; Fonarow GC; Shivkumar K
    Am J Cardiol; 2007 Jan; 99(2):242-6. PubMed ID: 17223426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new biomarker of cardiac resynchronization therapy response: cGMP to mature BNP ratio.
    Yokoyama Y; Kataoka N; Nakai M; Matsuo A; Fujiwara A; Wakamiya A; Ueda N; Nakajima K; Kamakura T; Wada M; Yamagata K; Ishibashi K; Inoue Y; Miyamoto K; Nagase S; Noda T; Aiba T; Takahama H; Izumi C; Kinugawa K; Minamino N; Kusano K
    J Cardiol; 2022 Jun; 79(6):727-733. PubMed ID: 35016810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain natriuretic peptide and cardiac resynchronization therapy in patients with mildly symptomatic heart failure.
    Brenyo A; Barsheshet A; Rao M; Huang DT; Zareba W; McNitt S; Hall WJ; Peterson DR; Solomon SD; Moss AJ; Goldenberg I
    Circ Heart Fail; 2013 Sep; 6(5):998-1004. PubMed ID: 23801020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac resynchronization therapy in patients with heart failure and moderately reduced ejection fraction: Could it trigger a super-response?
    Tawfik Ghanem M; Allam LE; Samir Ahmed R
    Indian Heart J; 2019; 71(3):229-234. PubMed ID: 31543195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and echocardiographic correlates of improvement in left ventricular diastolic function after cardiac resynchronization therapy.
    Aksoy H; Okutucu S; Kaya EB; Deveci OS; Evranos B; Aytemir K; Kabakci G; Tokgozoglu L; Ozkutlu H; Oto A
    Europace; 2010 Sep; 12(9):1256-61. PubMed ID: 20478931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
    Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
    J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biomarkers of inflammation in patients with chronic heart failure and implanted devices for cardiac resynchronization therapy].
    Kuznetsov VA; Soldatova AM; Enina TN; Shebeko PV; Rychkov AIu; Mel'nikov NN; Zateĭshchikov DA
    Kardiologiia; 2012; 52(8):38-43. PubMed ID: 23098397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of NT-pro BNP monitoring to identify echocardiographic responders following cardiac resynchronization therapy.
    Magne J; Dubois M; Champagne J; Dumesnil JG; Pibarot P; Philippon F; O'Hara G; Sénéchal M
    Cardiovasc Ultrasound; 2009 Aug; 7():39. PubMed ID: 19695099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathoracic impedance changes reflect reverse left ventricular remodeling in response to cardiac resynchronization therapy in chronic heart failure patients.
    Kaneshiro T; Suzuki H; Yamada S; Kamiyama Y; Saitoh S; Takeishi Y
    Int Heart J; 2012; 53(4):249-52. PubMed ID: 22878804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effects of cardiac resynchronization therapy on arterial distensibility and serum norepinephrine levels in advanced heart failure.
    Yildiz M; Hasdemir H; Turkkan C; Astarcioglu MA; Alper AT; Sahin A; Ozkan M
    Cardiol J; 2013; 20(3):304-9. PubMed ID: 23788305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.